Co-administration of fluoxetine and sumatriptan: The Canadian experience

Acta Psychiatrica Scandinavica

Volumn 95, Issue 6, 1997, Pages 551-552

  Joffe, R T ^a,b   Sokolov, S T H ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Depression; Fluoxetine; Migraine; Sumatriptan

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN;

ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG COMBINATION; DRUG INTERACTION; HUMAN; MIGRAINE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0030914321     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb10145.x     Document Type: Article

References (7)

1. BRESLAU N, DAVIS GC, ANDRESKI P. Migraine, psychiatric disorders and suicide attempts: an epidemiologic study of young adults. Psychiatr Res 1991: 37: 11-23.
2. MERIKANGAS KR, ANGST J, ISLER H. Migraine and psychopathology. Arch Gen Psychiatry 1990: 47: 849-853.
3. MERIKANGAS KR, RISCH NJ, MERIKANGAS JR, WEISSMAN MM, KIDD K. Migraine and depression: association and familial transmission. J Psychiatr Res 1988: 22: 119-129.
4. HUMPHREY PPA, FENIUCK W. Mode of action of the antimigraine drug sumatriptan. Trends Pharmacol Sci 1991: 12: 444-446.
5. BLIER P, BERGERON R. The safety of concomitant use of sumatriptan and antidepressant treatments. J Clin Psychopharmacol 1995: 15: 106-109.
6. SZABO CP. Fluoxetine and sumatriptan: possibly a counter-productive combination. J Clin Psychiatry 1995: 56: 37-38.
7. STERNBACH H. Serotonin syndrome. Am J Psychiatry 1991: 148: 705-713.